Indication
AIDS
4 clinical trials
5 products
2 drugs
Clinical trial
Expanded Access Protocol for Providing Tabelecleucel to Patients With Epstein-Barr Virus-Associated Viremia or Malignancies for Whom There Are No Appropriate Alternative TherapiesStatus:
Product
tabelecleucelClinical trial
A Phase 4 Study of the Effect on Immune Reconstitution of a Lopinavir/Ritonavir-Based Versus an Efavirenz-based HAART (Highly Active Antiretroviral Therapy) Regimen in Antiretroviral-Naïve Subjects With Advanced HIV DiseaseStatus: Terminated, Estimated PCD: 2010-12-01
Product
Lopinavir/RitonavirProduct
EfavirenzClinical trial
Short-Course EPOCH - Rituximab in Untreated CD-20+ HIV-Associated LymphomasStatus: Active (not recruiting), Estimated PCD: 2020-11-30
Drug
VarlilumabDrug
FilgrastimProduct
EPOCHClinical trial
Safety and Efficiency of Allogeneic Adoptive Immune Therapy for Advanced AIDS PatientsStatus: Recruiting, Estimated PCD: 2023-12-30